全球药物器械组合市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

全球药物器械组合市场需求预计将从 2022 年的 2203.5 亿美元达到 2030 年近 5048.8 亿美元的市场规模，2023-2030 年研究期间复合年增长率为 10.92%。

药物器械组合系统将一些医疗设备与药物或生物成分集成在一起，以改善药物输送。这些产品作为单一实体发挥作用，以实现所需的功效，这在传统的药物输送系统中通常是不存在的。组合产品必须经过严格的监管程序以维持安全和质量标准。由于这些项目包含来自不同监管团体的具有特定标准的组件，因此它们在监管许可期间受到持续监控。这些解决方案预计将代表多样化、高度复杂的临床技术和植入技术的功能增强。

市场动态：

因此，药物-器械组合产品的经济效益在全球范围内越来越受欢迎和相关。医疗器械行业的快速扩张、慢性病患病率的上升以及新产品发布数量的激增是预计推动药械组合产品需求的主要原因。此外，政府和私人对医学研究的支持增加了研发投资，以及新兴国家医疗保健意识的提高是预计推动全球医疗器械组合市场的几个原因。然而，高昂的运营费用和后续工作以及有关药物器械组合产品的限制性监管体係可能会阻碍市场增长。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球药物器械组合市场的每个细分市场进行了包容性评估。药物器械组合行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的药物器械组合市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。药物器械组合市场的主要参与者包括 Abbott、Terumo Corporation、Stryker Corporation、Mylan NV、Medtronic、Allergan plc、Boston Scientific Corporation、Novartis AG、CR Bard、Teleflex Incorporated、WL Gore & Associates Inc。竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市场亮点
• 全球市场概况

第 3 章：药物器械组合 - 行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 行业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原料厂商清单
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直效行销
  • 间接营销
  • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球药物器械组合市场分析：按产品

• 按产品概述
• 历史和预测数据
• 按产品分析
• 输液泵（容积式、一次性、注射器、流动式、植入式、胰岛素）
• 骨科组合产品（骨移植植入物、抗生素骨水泥）
• 光动力治疗仪
• 透皮贴剂
• 药物洗脱支架（冠状动脉支架、外周血管支架）
• 伤口护理产品
• 吸入器（干粉、雾化器、定量）
• 抗菌导管（泌尿、心血管、其他）
• 其他的

第 7 章：全球药物器械组合市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美按细分市场销售分析
  • 北美按国家/地区销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家/地区销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家/地区销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 8 章：药物器械组合公司的竞争格局

• 药物器械组合市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 9 章：公司简介

• 顶级公司市场份额分析
• 市场集中度
• Abbott
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Terumo Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Stryker Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Mylan NV
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Medtronic
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Allergan plc
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boston Scientific Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Novartis AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• CR Bard
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Teleflex Incorporated
• 公司简介
• 公司收入
• 产品
• 最近的发展
• WL Gore & Associates Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

The global demand for Drug Device Combination Market is presumed to reach the market size of nearly USD 504.88 BN by 2030 from USD 220.35 BN in 2022 with a CAGR of 10.92% under the study period 2023 - 2030.

Drug device combination systems integrate some medical equipment with medications or biological components to improve drug delivery. These products function as a single entity to achieve desired effectiveness, which is generally absent in conventional drug delivery systems. Combination products must undergo a rigorous regulatory procedure to maintain safety and quality standards. Because these items incorporate components from various regulatory groups with specific criteria, they are consistently monitored during regulatory clearances. These solutions are expected to represent a diverse, highly complex clinical technology and functional enhancements in implant technology.

MARKET DYNAMICS:

As a result, the financial benefits of drug-device combination products are increasing in popularity and relevance worldwide. Rapid expansion in the medical device industry, growing chronic illness prevalence, and an upsurge in the number of new product releases are the primary reasons expected to drive demand for drug-device combination products. Furthermore, government and private support for medical research increased R&D investment, and increased healthcare awareness in emerging nations are a few reasons anticipated to drive the worldwide medication device combination market. However, high operating expenses and follow-ups, as well as a restrictive regulatory system concerning drug-device combination products, can hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drug device combination. The growth and trends of drug device combination industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the drug device combination market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, Insulin)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Bone Cement)
• Photodynamic Therapy Devices
• Transdermal Patches
• Drug Eluting Stents (Coronary Stents, Peripheral Vascular Stents)
• Wound Care Products
• Inhalers (Dry Powder, Nebulizers, Metered Dose)
• Antimicrobial Catheters (Urological, Cardiovascular, Others)
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Drug Device Combination market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the drug device combination market include Abbott, Terumo Corporation, Stryker Corporation, Mylan N.V., Medtronic, Allergan plc, Boston Scientific Corporation, Novartis AG, C.R. Bard, Teleflex Incorporated, W. L. Gore & Associates Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . DRUG DEVICE COMBINATION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL DRUG DEVICE COMBINATION MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, Insulin) Historic and Forecast Sales by Regions
• 6.5 Orthopedic Combination Products (Bone Graft Implants, Antibiotic Bone Cement) Historic and Forecast Sales by Regions
• 6.6 Photodynamic Therapy Devices Historic and Forecast Sales by Regions
• 6.7 Transdermal Patches Historic and Forecast Sales by Regions
• 6.8 Drug Eluting Stents (Coronary Stents, Peripheral Vascular Stents) Historic and Forecast Sales by Regions
• 6.9 Wound Care Products Historic and Forecast Sales by Regions
• 6.10. Inhalers (Dry Powder, Nebulizers, Metered Dose) Historic and Forecast Sales by Regions
• 6.11 Antimicrobial Catheters (Urological, Cardiovascular, Others) Historic and Forecast Sales by Regions
• 6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL DRUG DEVICE COMBINATION MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DRUG DEVICE COMBINATION COMPANIES

• 8.1. Drug Device Combination Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF DRUG DEVICE COMBINATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Abbott
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Terumo Corporation
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Stryker Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Mylan N.V.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Medtronic
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Allergan plc
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Boston Scientific Corporation
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Novartis AG
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. C.R. Bard
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. Teleflex Incorporated
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments
• 9.13. W. L. Gore & Associates Inc.
  • 9.13.1. Company Overview
  • 9.13.2. Company Revenue
  • 9.13.3. Products
  • 9.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, Insulin) Market Sales by Geography (USD MN)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Bone Cement) Market Sales by Geography (USD MN)
• Photodynamic Therapy Devices Market Sales by Geography (USD MN)
• Transdermal Patches Market Sales by Geography (USD MN)
• Drug Eluting Stents (Coronary Stents, Peripheral Vascular Stents) Market Sales by Geography (USD MN)
• Wound Care Products Market Sales by Geography (USD MN)
• Inhalers (Dry Powder, Nebulizers, Metered Dose) Market Sales by Geography (USD MN)
• Antimicrobial Catheters (Urological, Cardiovascular, Others) Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Drug Device Combination Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Drug Device Combination Report
• Market Research Process
• Market Research Methodology
• Global Drug Device Combination Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, Insulin) Market Sales by Geography (USD MN)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Bone Cement) Market Sales by Geography (USD MN)
• Photodynamic Therapy Devices Market Sales by Geography (USD MN)
• Transdermal Patches Market Sales by Geography (USD MN)
• Drug Eluting Stents (Coronary Stents, Peripheral Vascular Stents) Market Sales by Geography (USD MN)
• Wound Care Products Market Sales by Geography (USD MN)
• Inhalers (Dry Powder, Nebulizers, Metered Dose) Market Sales by Geography (USD MN)
• Antimicrobial Catheters (Urological, Cardiovascular, Others) Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.